Skip to content

AGMB - Agomab Therapeutics NV - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchA

AgomAb Therapeutics NV American Depositary Shares

AGMB · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

A

AGMBAgomAb Therapeutics NV American Depositary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $17.82
52-wk low: $8.75
Prev close: $13.24
Mkt cap: $677.2M
P/B: 2.2x
Profit margin: +0.0%

Smart money

5 funds hold a position.

Real smart money

Funds holding this stock

5 holders

Combined position$20.7M

MI
Millennium
Israel Englander · Q1 2026 13F
$999K
position
CI
Citadel
Ken Griffin · Q1 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $677M

Valuation

P/B2.20

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: AGMB
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $677.16M

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Op margin

+0.0%

ROE

-39.2%

$367K

position

TS

Two Sigma

Q2 2026 13F

$235K

position

2 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 2 holders

Coverage gaps for AGMB

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

-39.2%

ROA-20.6%

Growth